Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Use of a Multitarget Fluorescence In Situ Hybridization Assay to Diagnose Bladder Cancer in Patients With Hematuria

5 Jun 2006

Abstract excerpt

PURPOSE: We evaluated the multitarget UroVysion fluorescence in situ hybridization assay for the diagnosis of bladder cancer in patients with hematuria and no history of bladder cancer. MATERIALS AND METHODS: A multicenter, blinded trial was performed to compare the sensitivity of the fluorescence in situ hybridization assay to that of voided cytology in patients with gross or microscopic hematuria. Confirmation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Esophageal Cancer Research and Treatment
Share to Urinary and Genital Oncology Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16753364
DOI: 10.1016/s0022-5347(06)00576-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Use of a Multitarget Fluorescence In Situ Hybridization Assay to Diagnose Bladder Cancer in Patients With HematuriaPMID 16753364Read ↗

Liquid biopsy based on multi-targeted capture of urinary tumor DNA combined with machine learning to detect urothelial carcinoma: a multicenter prospective study.Semantic proximity Read ↗

Bladder Cancer Detection Using FISH (UroVysion Assay)Semantic proximity Read ↗

Voided Urine Fluorescence In Situ Hybridization Testing for Upper Tract Urothelial Carcinoma SurveillanceSemantic proximity Read ↗

DNA Methylation Urine Biomarkers Test in the Diagnosis of Upper Tract Urothelial Carcinoma: Results from a Single-Center Prospective Clinical TrialSemantic proximity Read ↗

A cost-effective diagnostic approach of urothelial carcinomas in 2 mL full voided urine based on novel panels of dual methylated DNA markersSemantic proximity Read ↗

Multiprobe Fluorescence in situ Hybridization (UroVysion) for the Detection of Urothelial Carcinoma – FISHing for the Right CatchSemantic proximity Read ↗

A Urine-Based Liquid Biopsy Method for Detection of Upper Tract Urinary CarcinomaSemantic proximity Read ↗

BladMetrix: a novel urine DNA methylation test with high accuracy for detection of bladder cancer in hematuria patientsSemantic proximity Read ↗

A novel and sensitive DNA methylation marker for the urine-based liquid biopsies to detect bladder cancerSemantic proximity Read ↗

Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancerSemantic proximity Read ↗

Non-invasive detection of bladder cancer through the analysis of driver gene mutations and aneuploidySemantic proximity Read ↗

Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for CystoscopySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.